# A Study of a New Drug Treatment for Acne

> **NCT01326780** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 431 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** 1.2% JNJ 10229570-AAA
- **DRUG:** 2.4% JNJ 10229570-AAA
- **DRUG:** 3.6% JNJ 10229570-AAA
- **OTHER:** Vehicle control

## Key facts

- **NCT ID:** NCT01326780
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-31
- **Primary completion:** 2012-03-31
- **Final completion:** 2012-03-31
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326780, "A Study of a New Drug Treatment for Acne". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01326780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*